Women who decide they do not want to have children and want to pursue female sterilization, often face obstacles. It is common for women who request tubal ligation to be asked to wait for 30 days after signing a consent form, and some physicians are unwilling to perform the procedure. Many times it is easier for men to find a doctor willing to perform a vasectomy within a faster time frame.
UpToDate describes surgical sterilization as “a safe, highly effective, permanent, and convenient form of contraception.” If the procedure is performed with minimally invasive approach, recovery for women can have almost no down time. It can be done with small incisions, in an outpatient setting, allowing patients to return to their lives faster, with less pain.
The non-surgical alternative for women involves placement of nickel-titanium coils into fallopian tubes: the Essure device. This is done through a hysteroscopic procedure, with no need for incisions, and the fallopian tubes are expected to scar over the coils, naturally resulting in a permanent blockage at the opening of the uterus. It has been widely adopted and has become the standard of care for sterilization, but it’s also the most controversial of methods.
Over 10,000 complaints have been reported to the Food and Drug Administration by women who have had Essure coils, and suffered from side effects and symptoms that have extended beyond the pelvic cavity. Nearly 30,000 women have joined Essure Problems, an online support network for women who have been negatively affected by placement of the device. Essure side effects reported on the website includes hair and teeth loss, conditions related to gynecological, gastrointestinal, and neurological systems, autoimmune disorders, allergies, and more.
Get more facts about the female sterilization controversy, including new proposed legislation due to the increased risks of Essure placement, in this WTOP News article:
The Guise of Choice: The U.S. Female Sterilization Controversy
The non-surgical alternative for women involves placement of nickel-titanium coils into fallopian tubes: the Essure device. This is done through a hysteroscopic procedure, with no need for incisions, and the fallopian tubes are expected to scar over the coils, naturally resulting in a permanent blockage at the opening of the uterus. It has been widely adopted and has become the standard of care for sterilization, but it’s also the most controversial of methods.
Over 10,000 complaints have been reported to the Food and Drug Administration by women who have had Essure coils, and suffered from side effects and symptoms that have extended beyond the pelvic cavity. Nearly 30,000 women have joined Essure Problems, an online support network for women who have been negatively affected by placement of the device. Essure side effects reported on the website includes hair and teeth loss, conditions related to gynecological, gastrointestinal, and neurological systems, autoimmune disorders, allergies, and more.
Get more facts about the female sterilization controversy, including new proposed legislation due to the increased risks of Essure placement, in this WTOP News article:
The Guise of Choice: The U.S. Female Sterilization Controversy
MINIMALLY INVASIVE TUBAL LIGATION AND ESSURE REMOVAL AT CIGC
If you would like to discuss your options for safe minimally invasive tubal ligation or Essure removal with a CIGC physician [Paul MacKoul MD or Natalya Danilyants MD], call 888-SURGERY or contact us online. We are based in Rockville, MD and have offices in Annapolis, MD and Reston VA. Out-of-town patients can travel to Washington DC for minimally invasive GYN surgery through CIGC’s travel program.
Find Us On Social Media:
Paul MacKoul MD on Facebook | Natalya Danilyants MD on Facebook
Paul MacKoul MD on Twitter | Natalya Danilyants MD on Twitter
Paul MacKoul MD on LinkedIn | Natalya Danilyants MD on LinkedIn
If you would like to discuss your options for safe minimally invasive tubal ligation or Essure removal with a CIGC physician [Paul MacKoul MD or Natalya Danilyants MD], call 888-SURGERY or contact us online. We are based in Rockville, MD and have offices in Annapolis, MD and Reston VA. Out-of-town patients can travel to Washington DC for minimally invasive GYN surgery through CIGC’s travel program.
Find Us On Social Media:
Paul MacKoul MD on Facebook | Natalya Danilyants MD on Facebook
Paul MacKoul MD on Twitter | Natalya Danilyants MD on Twitter
Paul MacKoul MD on LinkedIn | Natalya Danilyants MD on LinkedIn